This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Wednesday's Health Winners & Losers

St. Jude Medical's (STJ - Get Report) shares gained 2.6% to $39.69 leading up to the company's quarterly earnings report slated for Thursday. A.G. Edwards analyst Jan Wald expects higher earnings in the third and fourth quarters, thanks to the company's new sales force.

Isis Pharmaceuticals (ISIS - Get Report) gained 2.6% to $10.67 after the company announced a private placement of its $125 million offering convertible subordinated notes due 2027. The company is also issuing an additional $37.5 million in notes at the initial purchasers' option.

Lexicon Genetics (LEXG) shares gained 2.4% to $3.42 after the company said it's initiating a trial on a proposed treatment for irritable bowel syndrome and other gastrointestinal disorders. The drug, dubbed LX1031, will be tested for safety and efficacy in approximately 40 healthy volunteers.

Shares of Affymax (AFFY) gained 5.9% to $34.96 after analysts at RBC Capital Markets and Cowen & Co. initiated coverage of the stock with outperform ratings. According to Cowen analyst Phil Nadeau, data on the company's drug Hematide show the drug is effective and safe. Nadeau expects the drug to enter the market as a treatment for kidney disease patients in 2010 and to treat cancer-related anemia in late in 2011.

Among other health stock winners Wednesday were Pfizer (PFE), 1.3% higher to $26.71; Emergent BioSolutions (EBS), gaining 8.6% to $17.38; NitroMed (NTMD), soaring 14.7% to $3.43; Novogen (NVGN), up 1.1% to $12.37; Cubist Pharmaceuticals (CBST), rising 2.6% to $18.06; and Introgen Therapeutics (INGN), whose shares were boosted 8.7% to $5.51.

Among the losers were The Medicines Co. (MDCO), falling 3.6% to $29.33; Trinity Biotech (TRIB), off 1% to $9.19; Geron (GERN), 1.3% higher to $8.42 and Novo Nordisk (NVO), down 1.2% to $84.80.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs